Skip to content
DataLookout
Menu

NCT07930247

Blood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential Hypertension

StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of patients achieving blood pressure control rates at Week 24 after treatment with Ex-one tablets or Ex-one Plus tablets
Timeframe: At Week 24 after enrollment

Sites

1 site in 1 country

  • HK inno.NSeoul, South Korea